Citadel Advisors
GOCO

Citadel Advisors’s GoHealth GOCO Stock Holding History

Citadel Advisors’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,136
Closed -$68.5K – 14893
2023
Q4 		$68.5K Hold
5,136
– – ﹤0.01% 11412
2023
Q3 		$74.4K Hold
5,136
– – ﹤0.01% 11255
2023
Q2 		$101K Buy
+5,136
New +$80.6K ﹤0.01% 10917
2022
Q4 		– Sell
-5,707
Closed -$30K – 15086
2022
Q3 		$30K Buy
5,707
+4,934
+638% +$37.1K ﹤0.01% 11907
2022
Q2 		$7K Sell
773
-127
-14% -$1.48K ﹤0.01% 12647
2022
Q1 		$16K Sell
900
-1,133
-56% -$35.3K ﹤0.01% 13296
2021
Q4 		$116K Sell
2,033
-1,714
-46% -$114K ﹤0.01% 12561
2021
Q3 		$283K Sell
3,747
-3,526
-48% -$373K ﹤0.01% 11168
2021
Q2 		$1.22M Sell
7,273
-8,294
-53% -$1.45M ﹤0.01% 7815
2021
Q1 		$2.73M Buy
15,567
+5,014
+48% +$1.01M ﹤0.01% 5671
2020
Q4 		$2.16M Buy
10,553
+6,073
+136% +$1.13M ﹤0.01% 5197
2020
Q3 		$875K Buy
+4,480
New +$1.08M ﹤0.01% 6270

Other funds holding GOCO

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors's GOCO Position: Q2 2025 in Review

Citadel Advisors sold out of GoHealth (GOCO) in Q2 2025, closing a stake of 27,036 shares — an estimated $332K sold.

Citadel Advisors first reported a position in GOCO in Q3 2020 and held it in 15 quarters. The position peaked at $13M in Q1 2021. 55 funds tracked by Wall St. Rank hold GOCO as of Q2 2025.

  • Citadel Advisors reported no remaining GoHealth position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 27,036 GoHealth shares in Q2 2025, an estimated $332K.
  • Citadel Advisors first reported a position in GoHealth in Q3 2020 and held it in 15 quarters.
  • Citadel Advisors's GoHealth position peaked at $13M in Q1 2021.
  • 55 funds tracked by Wall St. Rank held GoHealth as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.